UPC Analytics
DEEN
Übersicht · Eingereicht:

UPC_APP_5366/2025

FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Prozessuale & UnteranträgeSonstige prozessualeMilan CDGeneric application
Parteien

Kläger

  • Insulet Corporation
Vertreter: Marc Grunwald

Beklagte

  • EOFLOW Co., Ltd.
Vertreter: Ronald Mirko Weinert
Richter
  • Andrea PostiglioneJudge-Rapporteur
Patente
  • EP4201327
CPC-Codes: A61M5/1723, A61M5/1452, A61M5/158, A61B5/14865, A61M5/14244, F04B9/02, A61B5/14532, A61M2230/201, A61M2005/14506, A61M5/14248, B65D83/761, A61M5/3291

Sektor: Packaging & Conveying

Ausgang
Nur Kosten
Eingereicht:
Erste Entscheidung: 15. Feb. 2025
Sprache:

Procedural order from the Milan section of the Central Division (UPC_CFI_380/2024) on costs in preliminary injunction proceedings. EOFLOW applied for reimbursement of its costs incurred defending against Insulet's rejected preliminary injunction application. The Court ruled that costs of a preliminary phase must be settled at the time of the final merits decision, not parcelled out by procedural stage, and therefore deferred the costs question.